Drugs / Beclometasone/Formoterol/Glycopyrrolate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02040597 | Jan 2014 → Apr 2015 | chronic obstructive pulmonary disease | Chiesi Farmaceutici S.p.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Beclometasone/Formoterol/Glycopyrrolate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02040597 ↗ |
| Known as | CHF 5993 pMDI | “CHF 5993 pMDI” NCT02040597 ↗ |